SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Sanara MedTech Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$33.14−0.02 (-0.06%)

Close on Oct 19, 2026

Market cap: $287.08M
P/E (TTM): –
Dividend yield: –

Sanara MedTech Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Cash & Equivalents	17	16	5.15	8.96	19	0.46	6.61	0.18	0.46	0.83	0.18	0.52	0.04	0.05	0.00	0.05	0.00
Cash & Short-Term Investments	17	16	5.15	8.96	19	0.46	6.61	0.18	0.46	0.83	0.18	0.52	0.04	0.05	0.00	0.05	–
Receivables	12	–	–	6.81	2.86	0	–	–	–	–	–	–	–	–	0.06	0.45	–
Inventory	3.95	2.75	4.72	3.55	2.05	1.15	0.75	0.47	0.71	0.35	0.41	0.40	0.31	0.45	0.27	0.29	–
Prepaid Expenses & Other	0.95	1.02	0.61	1.10	0.92	0.61	0.16	0.03	0.03	0.02	0.11	0.01	0.08	0.01	0.10	0.11	–
Total Current Assets	34	33	19	21	25	4.48	8.86	1.69	2.04	2.00	1.16	1.21	0.65	1.04	1.59	1.05	–
Property, Plant & Equipment	0.46	0.43	1.26	1.42	1.63	0.68	0.20	0.02	0.06	0.03	0.04	0.05	0.03	0	0	0.00	–
Gross Property, Plant & Equipment	1.13	1.04	2.45	2.16	1.97	0.80	0.27	–	–	–	–	–	–	–	–	–	–
Accumulated Depreciation	-0.67	-0.61	-1.20	-0.74	-0.34	-0.12	-0.06	0.00	-0.06	-0.04	-0.03	-0.02	-0.02	–	–	–	–
Long-Term Investments	15	6.21	3.08	3.08	5.02	1.10	0	–	–	–	–	–	–	–	–	–	–
Equity Method Investments	14	5.21	–	–	–	–	–	–	0	–	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	2.08	1.45	2.00	0.81	0.41	0.47	0.59	0	–	–	–	–	–	–	–	–	–
Goodwill	3.60	3.60	3.60	3.60	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	19	23	45	32	4.73	3.10	1.47	0	0.12	0.14	0.19	0.24	0.29	0.34	0.43	4.11	–
Deferred Tax Assets	–	–	–	–	–	0	0	0	0	0	0	0	0	0	0	–	–
Other Long-Term Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0.03	–	–
Total Assets	73	88	74	61	36	9.83	11	1.71	2.22	2.17	1.39	1.50	0.98	1.39	3.83	6.78	–
Accounts Payable	2.34	–	–	1.39	0.44	0.27	0.34	0.16	0.23	0.24	0.22	0.21	0.19	0.21	0.00	0.32	–
Accrued Expenses	–	–	–	–	–	–	–	–	–	0	–	0	0.00	0.26	0.41	0.46	–
Current Portion of Long-Term Debt	–	–	0.58	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Debt	–	–	0.58	–	–	–	0	–	–	–	–	–	–	–	–	–	–
Current Portion of Leases	0.35	0.36	0.36	0.31	0.20	0.13	0.12	0	–	–	–	–	–	–	–	–	–
Other Current Liabilities	0.24	–	1.10	1.16	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	19	15	14	13	6.02	3.54	2.64	1.12	2.12	1.39	1.46	2.32	3.45	5.01	6.88	5.79	–
Long-Term Debt	46	31	9.11	–	–	–	–	–	–	–	–	–	–	0	0.28	–	–
Long-Term Leases	1.87	1.24	1.74	0.51	0.22	0.36	0.48	0	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	2.22	1.60	2.10	0.82	0.43	0.48	0.60	0	–	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	–	0.75	2.72	6.00	–	0.09	0	–	–	–	–	–	–	–	–	–	–
Total Liabilities	67	49	29	19	6.24	3.99	4.72	1.12	2.12	2.59	2.66	2.32	3.45	5.20	7.69	6.23	–
Total Debt	46	31	9.69	–	–	–	0	–	–	–	–	–	–	0	0.28	–	–
Preferred Stock	–	–	–	–	–	0	11	11	0.86	0.86	–	–	–	0	0	–	–
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0	0.11	0.11	0.11	0.11	0.09	0.07	0.06	0.04	–
Additional Paid-In Capital	81	77	73	65	46	13	-2.08	-11	46	46	45	44	40	35	33	25	–
Retained Earnings	-75	-38	-28	-23	-15	-7.03	-2.68	0.14	-47	-47	-47	-45	-43	-39	-37	-24	–
Treasury Stock	–	–	–	–	–	–	–	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	0.01	0.01	–
Shareholders' Equity	5.94	39	45	42	31	6.15	6.39	0.59	0.10	-0.42	-1.27	-0.83	-2.47	-3.81	-3.86	0.56	2.64
Noncontrolling Interest	-0.01	-0.49	-0.24	-0.11	-0.49	-0.31	-0.22	0	–	–	–	–	–	–	–	–	–
Total Equity	5.93	39	45	42	30	5.84	6.39	0.59	0.10	-0.42	-1.27	-0.83	-2.47	-3.81	-3.86	0.56	2.64
Total Liabilities & Equity	73	88	74	61	36	9.83	11	1.71	2.22	2.17	1.39	1.50	0.98	1.39	3.83	6.78	–
Shares Outstanding(shares)	8.95	8.75	8.54	8.30	7.68	6.30	3.57	0	1.13	1.10	1.07	0.93	0.86	0.69	0.59	0.41	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 93.0%
Operating margin: 7.7%
Net margin: -29.2%
Return on equity, FY2025: -165.7%

Financial strength

Current ratio: 2.58
Debt to equity: 5.85
Debt to assets: 67.2%
Cash to current liabilities: 123.4%

Valuation

P/E ratio: –
Price to sales: 2.61
Price to book: 36.14
Dividend yield: –